Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Ultragenyx Pharmaceutical	BridgeBio Pharma	Ascendis Pharma A/S	Ionis Pharmaceuticals	ACADIA Pharmaceuticals
Symbol	NASDAQ:RARE	NASDAQ:BBIO	NASDAQ:ASND	NASDAQ:IONS	NASDAQ:ACAD
Price Information
Current Price	$140.48	$72.03	$156.07	$54.31	$49.57
52 Week Range	Buy	Buy	Buy	Hold	Buy
MarketRank™
Overall Score	1.2	1.6	1.3	1.4	1.6
Analysis Score	2.3	2.4	2.5	3.1	2.5
Community Score	3.3	2.4	2.6	2.3	3.2
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	2.5	0.8	1.7	1.7
Earnings & Valuation Score	0.6	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$124.73	$61.22	$183.00	$61.00	$61.73
% Upside from Price Target	-11.21% downside	-15.00% downside	17.26% upside	12.32% upside	24.54% upside
Trade Information
Market Cap	$9.48 billion	$10.52 billion	$8.28 billion	$7.33 billion	$7.79 billion
Beta	2.19	0.82	0.77	1.42	1.44
Average Volume	467,258	1,179,663	185,961	904,166	903,613
Sales & Book Value
Annual Revenue	$103.71 million	$40.56 million	$14.98 million	$1.12 billion	$339.08 million
Price / Sales	90.69	264.24	556.52	6.81	23.24
Cashflow	N/A	N/A	N/A	$2.21 per share	N/A
Price / Cash	N/A	N/A	N/A	24.55	N/A
Book Value	$11.32 per share	$3.83 per share	$15.87 per share	$11.98 per share	$4.54 per share
Price / Book	12.41	18.81	9.83	4.53	10.92
Profitability
Net Income	$-402,730,000.00	$-260,590,000.00	$-244,180,000.00	$303.26 million	$-235,260,000.00
EPS	($7.36)	($2.48)	($5.25)	$2.08	($1.60)
Trailing P/E Ratio	N/A	N/A	N/A	113.15	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-119.19%	N/A	-4,042.79%	7.82%	-63.92%
Return on Equity (ROE)	-50.69%	-109.88%	-55.72%	6.57%	-40.35%
Return on Assets (ROA)	-26.87%	-48.54%	-49.42%	3.39%	-34.72%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	2.19%	N/A	0.51%	N/A
Current Ratio	4.33%	9.85%	14.80%	10.37%	7.95%
Quick Ratio	4.26%	9.85%	14.80%	10.28%	7.86%
Ownership Information
Institutional Ownership Percentage	N/A	95.53%	N/A	84.14%	93.54%
Insider Ownership Percentage	8.20%	40.32%	40.00%	2.40%	27.70%
Miscellaneous
Employees	740	369	330	817	580
Shares Outstanding	66.95 million	148.79 million	53.42 million	140.86 million	158.98 million
Next Earnings Date	5/5/2021 (Estimated)	5/12/2021 (Estimated)	4/7/2021 (Estimated)	5/5/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Optionable	Not Optionable	Optionable	Optionable	Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Premium Research Tools

Market Data and Calendars

Investing Education and Resources